StudyProtocol is a startup dedicated to revolutionizing the way clinical trials are conducted. With the mission of improving patient recruitment, the company aims to streamline the process through its cutting-edge software solution. Founded in 2019, StudyProtocol operates in the industries of Cloud Infrastructure, Health Care, Information Technology, Internet, Life Sciences, Pharmaceutical, and Human Resources.
The company's platform is designed to optimize patient recruitment efforts, enabling trial managers to track progress and make informed decisions for successful clinical trials. StudyProtocol is focused on advancing medical research, empowering researchers, physicians, and trial managers to bring new treatments and cures to the world more efficiently. The company's commitment to making a positive impact in the lives of people everywhere positions it as a promising player in the field of medical research.
There is no investment information
No recent news or press coverage available for StudyProtocol.